CENTIVIS’ Founder, Norbert Farkas has recently presented on EuroMedLab 2019.
Abstract
In Vitro Diagnostics (IVD) operating environment is changing rapidly and getting more complex to operate in. Regulators and Payers increase policy scrutiny, diagnostic solutions require more, and better clinical evidence and digital diagnostic solutions challenge the status quo. On the other hand, health care systems face significant cost pressure, innovation cycles are getting shorter and solutions more technologically advanced.
The question emerges: how can patients benefit from broad access to new innovative diagnostic solutions in such a rapidly changing environment?
The presentation briefly covers key trends, impacting IVD business and focuses on the emerging global importance of Payers in product development and commercialization.
The talk introduces the main Payer challenges, potential solutions and in a simple, 5-step framework covers the key success criteria of successfully securing reimbursement, leading to broad patient access, adoption.
In the last section, industry-leading market access best practices are demonstrated based on real-life company and product examples.